Last reviewed · How we verify
Anti-GITR Agonistic Monoclonal Antibody BMS-986156
At a glance
| Generic name | Anti-GITR Agonistic Monoclonal Antibody BMS-986156 |
|---|---|
| Also known as | Anti-GITR MoAb BMS-986156, BMS 986156, BMS-986156, GITR Agonist BMS-986156, TNFRSF18 Agonist BMS-986156 |
| Sponsor | M.D. Anderson Cancer Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Rash
- Dyspnea
- Fatigue
- Abdominal pain
- Diarrhea
- Cough
- Generalized muscle weakness
- Anorexia
- Back pain
- Edema limbs
- Nausea
- Weight loss
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: